Supplementary Table S6 from TPP-45142—an Anti-HER2 T-cell Engager—Designed for Selective HER2-Low Cancer Immunotherapy
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Supplementary Table S6 shows PK parameters calculated from the exposure of the 89Zr-labeled NANOBODY molecules in blood samples of ZR-75-1 tumor-bearing NSG mice engrafted with in vitro expanded T cells
Fields of Study & Subjects
Monoclonal and Polyclonal Antibodies Research
Radiopharmaceutical Chemistry and Applications
HER2/EGFR in Cancer Research
Publication details
- Publication date
- 2 April 2026
- Language
- EN